About
Basic Data Updated:
1 month agoThe Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1,000.00 and a paid-up capital of Rs 1,000.00, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Centre For Cellular And Molecular Platforms India is Taslimarif Saiyed as Ceo. Shrikumar Suryanarayan, Satyajit Mayor, Manoj Kumar, and Two other members serve as directors at the Company.
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U73200KA2010NPL052117 |
| Company No. | 052117 |
| Company Classification | Private Not For Profit Company |
| Incorporation Date | 08 Jan 2010 |
| Date of AGM | 21 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Bangalore |
Financials of Centre For Cellular And Molecular Platforms
Centre For Cellular And Molecular Platforms, for the financial year ended 2023, experienced modest growth in revenue, with a 7.44% increase. The company also saw a slight improvement in profitability, with a 8.65% increase in profit. The company's net worth moved up by a moderate rise of 9.68%.
Corporate Structure
Unlock access to Centre For Cellular And Molecular Platforms's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Centre For Cellular And Molecular Platforms
Unlock and access historical data on people associated with Centre For Cellular And Molecular Platforms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
TS
Taslimarif Saiyed
CEOAppointment Date: 21-Apr-2017
Status: Current
Board Members(5)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centre For Cellular And Molecular Platforms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centre For Cellular And Molecular Platforms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Escape Velocity Accelerator India Private Limited
Active
10 years 7 months Shrikumar Suryanarayan is a mutual person
Recent activity within the organization
Annual General Meeting
Centre For Cellular And Molecular Platforms last Annual general meeting of members was held on 21 Sep 2023 as per latest MCA records.
21 Sep 2023Balance Sheet
Centre For Cellular And Molecular Platforms has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Director Appointment
Manoj Kumar was appointed as a Director was appointed as a Director on 20 Sep 2019 & has been associated with this company since 5 years 2 days .
20 Sep 2019Director Appointment
Taslimarif Turabmiya Saiyed was appointed as a Director was appointed as a Director on 04 Apr 2017 & has been associated with this company since 7 years 5 months .
04 Apr 2017Director Appointment
Shrikumar Suryanarayan was appointed as a Director was appointed as a Director on 19 Mar 2010 & has been associated with this company since 14 years 6 months .
19 Mar 2010
Recent News, Updates & Announcement
Assam Govt CCAMP Partner for Enhanced Public Healthcare Tech Adoption Infrastructure Upgrades CapacityBuilding in Focus.Assam govt and CCAMP team up to improve public healthcare MoU signed for tech adoption infrastructure upgrades and capacitybuilding Projects include respiratory support vaccine carriers and oxygensupported hospital Goal better healthcare for all especially in areas like cancer screening Lets work together for a healthier Assam.
IndiaMedToday 29 Dec 2023
- CCAMP partners with VC fund to fund deepscience innovations in India.
BioSpectrum India 06 Jul 2023
- CCAMP receives CSR support from Cytiva to foster earlystage innovations in India.
BioSpectrum India 30 May 2023
- Janitri closes preSeries A at 11 mn from iAngels backed by India Accelerator.
Janitri provides advanced wearables and solutions for pregnancy and labor vitals monitoring.
Economic Times 03 May 2023
- Centre for Cellular and Molecular Platforms CCAMP unveils .
BioSpectrum India 02 Feb 2023
Frequently asked questions
What is the Incorporation or founding date of Centre For Cellular And Molecular Platforms?
